Vertex Pharmaceuticals | VRTX - Créances Commerciales

Prix De L'Action
423.24
Variation Quotidienne
-6.90 -1.60%
Mensuellement
-4.50%
Annuel
-16.93%
Q2 Prévisions
421.08




Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Biogen USD 1.87B 17M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
United Therapeutics USD 350.2M 52.5M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12